PMID- 35100480 OWN - NLM STAT- MEDLINE DCOM- 20220506 LR - 20220506 IS - 1097-0339 (Electronic) IS - 1097-0339 (Linking) VI - 50 IP - 6 DP - 2022 Jun TI - A rare case of intracytoplasmic mucin-rich nasopharyngeal carcinoma. PG - E151-E155 LID - 10.1002/dc.24934 [doi] AB - Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated tumor with a high incidence in Asian countries. NPC is a type of squamous cell carcinoma originating from the nasopharyngeal mucosa. Although rare, NPCs show some uncommon histologic variants; these variations remain to be understood. We described the cytologic characteristics of a rare NPC variant with abundant intracytoplasmic mucin. A 37-year-old Japanese man presented to our hospital with bilateral ear discomfort and palpable lymph nodes. Nasopharyngeal biopsy showed tumor cells with abundant intracytoplasmic, Alcian blue-PAS-positive mucin. Immunohistochemical analysis demonstrated that the tumor cells were positive for p40 and p53. Epstein-Barr encoding region (EBER) in situ hybridization (ISH) showed EBV infection of the tumor cells. Fluorescence in situ hybridization (FISH) using MAML2 break-apart probes did not show split signals. Fine needle aspiration biopsy (FNAB) cytology of the metastatic lymph nodes was also performed. Smear samples had a necrotic and inflammatory background with both lymphocyte and neutrophil infiltration. Highly cellular tumor clusters and dispersed cells with naked nuclei were observed. The tumor cells showed a clear cytoplasm with distinct cell borders. Intracytoplasmic mucin pushing the nucleus to the periphery was observed in the scattered tumor cells in a liquid-based cytology sample. Given these findings, the final diagnosis was advanced nasopharyngeal carcinoma; cisplatin-based chemoradiation therapy was performed as the first-line treatment. The tumor recurred 8 months after completing the treatment. The recurrent nasopharyngeal tumor was a typical non-keratinizing NPC and lacked intracytoplasmic mucin. CI - (c) 2022 Wiley Periodicals LLC. FAU - Yamaguchi, Yohei AU - Yamaguchi Y AUID- ORCID: 0000-0002-1060-9018 AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. FAU - Odate, Toru AU - Odate T AUID- ORCID: 0000-0001-6273-2192 AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. FAU - Nakazawa, Kumiko AU - Nakazawa K AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. FAU - Oishi, Naoki AU - Oishi N AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. FAU - Mochizuki, Kunio AU - Mochizuki K AUID- ORCID: 0000-0001-9577-0320 AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. FAU - Shimizu, Tatsuya AU - Shimizu T AD - Department of Radiology, University of Yamanashi, Yamanashi, Japan. FAU - Horiuchi, Kiwako AU - Horiuchi K AD - Department of Otolaryngology, Head and Neck Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Ishii, Hiroki AU - Ishii H AD - Department of Otolaryngology, Head and Neck Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Sakurai, Daiju AU - Sakurai D AD - Department of Otolaryngology, Head and Neck Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Kondo, Tetsuo AU - Kondo T AD - Department of Pathology, University of Yamanashi, Yamanashi, Japan. LA - eng PT - Case Reports PT - Journal Article DEP - 20220131 PL - United States TA - Diagn Cytopathol JT - Diagnostic cytopathology JID - 8506895 RN - 0 (Mucins) SB - IM MH - *Epstein-Barr Virus Infections/diagnosis MH - Herpesvirus 4, Human/genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Mucins MH - Nasopharyngeal Carcinoma/diagnosis MH - *Nasopharyngeal Neoplasms/diagnosis OTO - NOTNLM OT - Epstein-Barr virus OT - cytology OT - lymph node OT - mucin OT - nasopharyngeal carcinoma EDAT- 2022/02/01 06:00 MHDA- 2022/05/07 06:00 CRDT- 2022/01/31 17:16 PHST- 2022/01/18 00:00 [revised] PHST- 2021/12/06 00:00 [received] PHST- 2022/01/19 00:00 [accepted] PHST- 2022/02/01 06:00 [pubmed] PHST- 2022/05/07 06:00 [medline] PHST- 2022/01/31 17:16 [entrez] AID - 10.1002/dc.24934 [doi] PST - ppublish SO - Diagn Cytopathol. 2022 Jun;50(6):E151-E155. doi: 10.1002/dc.24934. Epub 2022 Jan 31.